Drug-induced liver injury. In vitro demonstration of hypersensitivity to both phenytoin and phenobarbital.
Fever, lymphadenopathy, exfoliative dermatitis, and evidence of drug-induced liver injury developed in a 16-year-old girl three weeks after beginning therapy with phenytoin and phenobarbital. This clinical syndrome can be caused by either of these structurally related drugs but has been more frequently attributed to phenytoin. In vitro studies disclosed marked reactivity of this patient's lymphocytes to concentrations of both drugs, which encompassed their measured serum levels. The demonstration of dual reactivity raises concerns about continuing administration of phenobarbital during an apparent phenytoin-induced reaction. Whether this potential risk is greater than the risk of stopping all anticonvulsant medications in a patient with a seizure disorder is not known and remains to be established.
D000293:Adolescent; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000276:immunology; D003429:Cross Reactions; D004342:Drug Hypersensitivity / Q000276:immunology*; D005260:Female; D006801:Humans; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects; D010634:Phenobarbital / Q000009:adverse effects* / Q000494:pharmacology; D010672:Phenytoin / Q000009:adverse effects* / Q000494:pharmacology
D010672:Phenytoin; D010634:Phenobarbital